NASDAQ:FPRX
Delisted
Five Prime Therapeutics Stock News
$38.00
+0 (+0%)
At Close: May 27, 2022
Head of big South San Francisco biotech thriving in first CEO role
06:54pm, Friday, 20'th Dec 2019
New York-born, Bay Area-raised Brian Wong is doing the hard work of broadening a drug pipeline with what he describes as a “Brooklyn toughness."
Edited Transcript of FPRX earnings conference call or presentation 6-Nov-19 9:30pm GMT
11:17pm, Monday, 16'th Dec 2019
Q3 2019 Five Prime Therapeutics Inc Earnings Call
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy ?
04:14pm, Tuesday, 10'th Dec 2019
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018. Trends reversed 180 degrees in 2019 amid Powell's pivot and opti
The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
12:00am, Wednesday, 20'th Nov 2019Analysts Offer Predictions for Five Prime Therapeutics Inc’s FY2019 Earnings (NASDAQ:FPRX)
10:33am, Wednesday, 13'th Nov 2019
Five Prime Therapeutics Inc (NASDAQ:FPRX) – Research analysts at Svb Leerink lifted their FY2019 EPS estimates for shares of Five Prime Therapeutics in a note issued to investors on Wednesday, Novem
Insiders Roundup: Crocs, OPKO Health
06:02pm, Friday, 08'th Nov 2019
Largest insider trades of the week Continue reading...
Five Prime Therapeutics (FPRX) Reports Q3 Loss, Misses Revenue Estimates
11:45pm, Wednesday, 06'th Nov 2019
Five Prime Therapeutics (FPRX) delivered earnings and revenue surprises of -8.42% and -31.02%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the
